Dr. Paul K. Wotton is Obsidian’s Chief Executive Officer, bringing significant experience spanning scientific research, product development and corporate growth gained over a thirty-year career. Dr. Wotton most recently served as the Founding President and CEO of Sigilon Therapeutics, Inc. Prior to Sigilon, Dr. Wotton served as President and Chief Executive Officer of Ocata Therapeutics until […]

As the COVID-19 pandemic continues, a telehealth company known as NOCD is continuing to treat people suffering from Obsessive Compulsive Disorder, all from the convenient platform of an app. Founded in 2014, NOCD provides virtual therapy and support sessions to patients suffering with OCD.

→ Entrenched in a legal battle with their manufacturer that’s evidently blocking them from making their Covid-19 vaccine candidate, Inovio is making some leadership changes. Gene Kim will be president of Inovio Asia, while Mammen (Anza) Mammen jumps aboard the biotech as SVP, clinical development, and is slated oversee development of Inovio’s DNA vaccine candidate INO-4800. An […]